VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/28/2026

1. FFIV
2. CDNS
3. XFLT
4. META
5. TFII
6. SPGI
7. NVDA
8. AMZN
9. CORZ
10. DINO

Go back to VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology
VolitionRX Limited (NYSE: VNRX) Delayed: 0.88 --0 (-0%)
Previous Close $0.88    52 Week High $5.86 
Open $0.88    52 Week Low $3.05 
Day High $0.88    P/E N/A 
Day Low $0.88    EPS $-0.45 
Volume 3,033       

VolitionRX Limited (NYSE: VNRX) Delayed: 0.88 --0 (-0%)
Previous Close $0.88    52 Week High $5.86 
Open $0.88    52 Week Low $3.05 
Day High $0.88    P/E N/A 
Day Low $0.88    EPS $-0.45 
Volume 3,033